Abstract:Chagas disease is a zoonosis caused by the protozoan parasite Trypanosoma cruzi . Clinical outcomes range from long-term asymptomatic carriage to cardiac, digestive, neurological and composite presentations that can be fatal in both acute and chronic stages of the disease. Studies of T . cruzi in animal models, principally mice, have informed our understanding of the biological basis of this variability and its relationship to infection and host response dynamics. Hamsters have higher translational value for many human infectious diseases, but they have not been well developed as models of Chagas disease. We transposed a real-time bioluminescence imaging system for T . cruzi infection from mice into female Syrian hamsters ( Mesocricetus auratus ). This enabled us to study chronic tissue pathology in the context of spatiotemporal infection dynamics. Acute infections were widely disseminated, whereas chronic infections were almost entirely restricted to the skin and subcutaneous adipose tissue. Neither cardiac nor digestive tract disease were reproducible features of the model. Skeletal muscle had only sporadic parasitism in the chronic phase, but nevertheless displayed significant inflammation and fibrosis, features also seen in mouse models. Whereas mice had normal locomotion, all chronically infected hamsters developed hindlimb muscle hypertonia and a gait dysfunction resembling spastic diplegia. With further development, this model may therefore prove valuable in studies of peripheral nervous system involvement in Chagas disease. Chagas disease is a caused by American trypanosomes ( Trypanosoma cruzi ). These are microscopic parasites that circulate in wild mammals across most of the Americas and can also be transmitted to humans. Much of our knowledge about how T . cruzi causes Chagas disease comes from studies of infections in mice, but the data do not capture the full range of clinical outcomes seen in humans. For many other pathogens the hamster has proved to be a valuable model of human infections. We therefore aimed to apply some of the latest advances in T . cruzi infection imaging technology to studies in this alternative experimental model. In the early stages, parasites were widely disseminated throughout the body, but after several months parasites became almost entirely restricted to the skin. Hamsters did not show signs of heart or gut disease, which are common in humans, but they did develop skeletal muscle pathology. Stiffness in the hindlimbs grew progressively worse and resulted in a visibly altered gait, suggestive of damage to the nervous system. With further development, this model may therefore prove valuable in studies of peripheral nervous system involvement in Chagas disease.

A panel of phenotypically and genotypically diverse bioluminescent:fluorescent strains as a resource for Chagas disease research

A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research

Animal models for exploring Chagas disease pathogenesis and supporting drug discovery

Challenges in Chagas Disease Drug Development

What are the translational challenges associated with Chagas disease drug discovery?

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery

Animal models of Chagas disease and their translational value to drug development

Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy

Adaptations in energy metabolism and gene family expansions revealed by comparative transcriptomics of three Chagas disease triatomine vectors

Phenotypic screening approaches for Chagas disease drug discovery

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection

High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery

Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease

Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease

A guide for the generation of repositories of clinical samples for research on Chagas disease

Diversity of Chagas disease diagnostic antigens: Successes and limitations

Quantitative Proteomic Analysis of Macrophages Infected with Trypanosoma cruzi Reveals Different Responses Dependent on the SLAMF1 Receptor and the Parasite Strain

Dynamics of Trypanosoma cruzi infection in hamsters and novel association with progressive motor dysfunction

Molecular tools to regulate gene expression in Trypanosoma cruzi

Gene expression profiling of Trypanosoma cruzi in the presence of heme points to glycosomal metabolic adaptation of epimastigotes inside the vector

Lab on a chip (LOC) platform for drug screening against the intracellular forms of Trypanosoma cruzi